Recursion is discovering transformative new treatments by combining automation, machine learning, and the world’s largest biological image datasets.
-
2013 - Founded
-
2017 - Partnered, Series B
-
2021 - IPO; NASDAQ: RXRX
Leadership
Chris Gibson
Founder & CEO
